Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. R 848
2. R-848
3. R848 Compound
1. 144875-48-9
2. R-848
3. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol
4. 1-[4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
5. Resiquimod [inn]
6. R 848
7. Resiquimod (r-848)
8. R848
9. S 28463
10. S-28463
11. V3dmu7pvxf
12. Mfcd00937759
13. Chembl383322
14. Chebi:36706
15. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
16. Cd11301
17. Cd-11301
18. R848;s28463
19. 2252319-44-9
20. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol.
21. 1h-imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-
22. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
23. R848 Compound
24. Unii-v3dmu7pvxf
25. 1h-imidazo(4,5-c)quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-
26. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol
27. Resiquimodr848
28. Vml-600
29. Rx8
30. R848; Resiquimod
31. S28463
32. Resiquimod [mi]
33. Resiquimod [usan]
34. Resiquimod [mart.]
35. Resiquimod [who-dd]
36. Schembl34159
37. Mls006010212
38. Alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol
39. Gtpl5051
40. Dtxsid7040603
41. Resiquimod, >=98% (hplc)
42. Hms3740o09
43. Bcp09103
44. Ex-a1879
45. Bdbm50241029
46. S8133
47. Zinc28572103
48. Akos016003509
49. Ccg-267635
50. Cs-1706
51. Db06530
52. Sb17111
53. 1-(4-amino-2-ethoxymethyl-imidazo[4,5-c]quinolin-1-yl)-2-methyl-propan-2-ol
54. Ncgc00370784-01
55. Ncgc00370784-05
56. Ac-35716
57. As-30885
58. Hy-13740
59. Smr002530531
60. Sy107476
61. Ft-0763049
62. R0197
63. Resiquimod, Vml-600, R-848, S-28463
64. A856222
65. Q426054
66. Sr-01000944954
67. J-008020
68. Sr-01000944954-1
69. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methyl-propan-2-ol
70. 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
71. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinolin-1-ethanol
72. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
Molecular Weight | 314.4 g/mol |
---|---|
Molecular Formula | C17H22N4O2 |
XLogP3 | 1.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 314.17427596 g/mol |
Monoisotopic Mass | 314.17427596 g/mol |
Topological Polar Surface Area | 86.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 406 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in genital herpes.
Resiquimod is a Toll-like receptor 7 (TLR7) and TLR8 agonist that is a potent inducer of alpha interferon (IFN-alpha) and other cytokines.
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
13
PharmaCompass offers a list of Resiquimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Resiquimod manufacturer or Resiquimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Resiquimod manufacturer or Resiquimod supplier.
PharmaCompass also assists you with knowing the Resiquimod API Price utilized in the formulation of products. Resiquimod API Price is not always fixed or binding as the Resiquimod Price is obtained through a variety of data sources. The Resiquimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A R848 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of R848, including repackagers and relabelers. The FDA regulates R848 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. R848 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A R848 supplier is an individual or a company that provides R848 active pharmaceutical ingredient (API) or R848 finished formulations upon request. The R848 suppliers may include R848 API manufacturers, exporters, distributors and traders.
click here to find a list of R848 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A R848 DMF (Drug Master File) is a document detailing the whole manufacturing process of R848 active pharmaceutical ingredient (API) in detail. Different forms of R848 DMFs exist exist since differing nations have different regulations, such as R848 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A R848 DMF submitted to regulatory agencies in the US is known as a USDMF. R848 USDMF includes data on R848's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The R848 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of R848 suppliers with USDMF on PharmaCompass.
R848 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of R848 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right R848 GMP manufacturer or R848 GMP API supplier for your needs.
A R848 CoA (Certificate of Analysis) is a formal document that attests to R848's compliance with R848 specifications and serves as a tool for batch-level quality control.
R848 CoA mostly includes findings from lab analyses of a specific batch. For each R848 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
R848 may be tested according to a variety of international standards, such as European Pharmacopoeia (R848 EP), R848 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (R848 USP).